Ads Disclaimer


Teva Pharmaceutical Industries, Ltd. (TEVA)
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients. Teva is among the top 15 pharmaceutical companies and among the largest generic pharmaceutical companies in the world.

With more than a century of experience in the healthcare industry, the Company enjoys a firmly established international presence, operating through a carefully tailored network of worldwide subsidiaries. Headquartered in Israel, above 80% of Teva's sales, which totaled US$13.9 billion in 2009, are in North America and Europe. Teva has over 35,000 employees worldwide and production facilities in Israel, North America, Europe and Latin America.

The History of Teva

21st Century - Global Leadership

In the year 2000, Teva's acquisition of Novopharm in Canada, together with its Hungarian subsidiary Teva Pharmaceutical Works Ltd. Hungary (formerly Human Ltd), led Teva to become the largest generic pharmaceutical company in North America.

Teva continued to expand its presence worldwide with the acquisition in 2002 of Teva Classics (previously Bayer) in France, which included the Teva Sante' manufacturing plant in Sens. And finally the acquisition of the Honeywell Fine Pharmaceutical Chemical plants in northern Italy, renamed Teva PFC, has added to the range of Teva's API products manufactured worldwide.

On January 22, 2004, Sicor became a wholly owned subsidiary of Teva. This acquisition brings together two premier generic pharmaceutical companies, combining Teva's successful oral dose generic drugs franchise with Sicor's leading generic injectable business. In addition, both the Active Pharmaceutical Ingredients (API) businesses and Sicor's biogenerics capabilities will enhance and expand the combined company's product offerings.

On January 26, 2006, the acquisition of IVAX Corporation was finalized and IVAX is now a wholly owned subsidiary of Teva. IVAX Corporation discovers, develops, manufactures, and markets branded and brand equivalent (generic) pharmaceuticals and veterinary products in the U.S. and internationally. IVAX brings a strong presence in Latin America and in Central and Eastern Europe and complementary operations in North America and Europe. IVAX also brings complementary product lines in generics, a significant respiratory business, and a rich pipeline of generic and proprietary products in the areas of respiratory, CNS, and oncology. The combined company will offer the widest range of cost-effective pharmaceuticals, both generic and branded, to consumers, customers, and healthcare providers.

In December 2008, Teva has completed its acquisition of Barr Pharmaceuticals in the US and its European subsidiary Pliva. This acquisition will further enhance Teva's leadership position in the U.S. and will significantly strengthen its position in key European and Central and Eastern European markets. The combined company will have a significant presence in over 60 countries and will have a highly complementary generics business in the U.S. which extends its product portfolio and pipeline into new and product categories.

With over a century of experience in the health care industry the company enjoys firmly established international presence, operating through a strategic tailored network of worldwide subsidiaries. Teva has major manufacturing and marketing facilities in Israel, Europe and the US.

Today, Teva is among the top 15 pharmaceutical companies in the world and one of the largest generic pharmaceutical companies in the world.

Teva is among the most traded shares on the Tel Aviv Stock Exchange and among the most widely held Israeli shares on NASDAQ. It is also traded on Seaq International in London and the Frankfurt Stock Exchange.

Business Law & Financial Ethics Company Histories - Suggested Reading
Top of page Stock Maven® Glossary Search Stock Maven®


About Opinion / Technical Analysis
Search Stocks and Shares: Enter Symbol (Lookup):
Opinion Profile



Ads Disclaimer





Stock Maven is a registered trademark ®